These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11561213)

  • 1. Growth hormone and prolactin secretion after metoclopramide administration (DA2 receptor blockade) in fertile women.
    Cunha-Filho JS; Gross JL; Vettori D; Dias EC; Passos EP
    Horm Metab Res; 2001 Sep; 33(9):536-9. PubMed ID: 11561213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and growth hormone secretion after thyrotrophin-releasing hormone infusion and dopaminergic (DA2) blockade in infertile patients with minimal/mild endometriosis.
    Cunha-Filho JS; Gross JL; Lemos NA; Dias EC; Vettori D; Souza CA; Passos EP
    Hum Reprod; 2002 Apr; 17(4):960-5. PubMed ID: 11925390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle.
    Caufriez A; Leproult R; L'Hermite-Balériaux M; Moreno-Reyes R; Copinschi G
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):535-42. PubMed ID: 19222493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin secretion abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
    Raff SB; Carney JA; Krugman D; Doppman JL; Stratakis CA
    J Pediatr Endocrinol Metab; 2000 Apr; 13(4):373-9. PubMed ID: 10776991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion.
    Agner T; Hagen C; Andersen AN; Djursing H
    J Clin Endocrinol Metab; 1986 Apr; 62(4):778-82. PubMed ID: 3949956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
    Andersen AN; Tabor A
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the dopaminergic neuroendocrine control of prolactin release during labor in humans].
    Nishii O; Takeuchi T; Takahashi M; Okamura T; Yaginuma T; Kobayashi T
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):108-16. PubMed ID: 3699198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the degree of surgical trauma and glucose load on concentration of thyrotropin, growth hormone and prolactin under enflurane anaesthesia.
    Redondo M; Rubio V; de la Peña A; Morell M
    Horm Metab Res; 1997 Feb; 29(2):66-9. PubMed ID: 9105902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of altered dopaminergic modulation of Prl, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women.
    Hagen C; Andersen AN; Djursing H
    Acta Endocrinol (Copenh); 1984 May; 106(1):1-7. PubMed ID: 6428112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role and secretion of prolactin in the human fetus and neonate (author's transl)].
    Fukaya T; Furuhashi N; Kono H; Tachibana Y; Shinkawa O; Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1639-45. PubMed ID: 7310195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of growth hormone to metoclopramide in normal women and amenorrheic women with or without hyperprolactinemia.
    Seki K; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):721-5. PubMed ID: 3830074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased dopaminergic tone and increased basal bioactive prolactin in men with human immunodeficiency virus infection.
    Parra A; Ramírez-Peredo J; Larrea F; Cabrera V; Coutiño B; Torres I; Angeles A; Pérez-Romano B; Ruiz-Argüelles G; Ruiz-Argüelles A
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):731-8. PubMed ID: 11422107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ghrelin and metoclopramide on prolactin secretion in normal women.
    Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Anifandis G; Messinis IE
    J Endocrinol Invest; 2011 Apr; 34(4):276-9. PubMed ID: 20530986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopaminergic blockade on the secretion of growth hormone and prolactin in man.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
    Metabolism; 1978 Aug; 27(8):921-6. PubMed ID: 672613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma GH, TSH, and PRL responses to recombinant human insulin-like growth factor-I (IGF-I) in normal and acromegalic subjects.
    Hanew K; Tanaka A; Sugawara A; Itoi K; Abe K
    Endocr J; 1996 Oct; 43 Suppl():S81-3. PubMed ID: 9076348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.